Stay updated on Nivo+Ipi +/- SBRT in Metastatic MCC Clinical Trial
Sign up to get notified when there's something new on the Nivo+Ipi +/- SBRT in Metastatic MCC Clinical Trial page.

Latest updates to the Nivo+Ipi +/- SBRT in Metastatic MCC Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoChange Detected- Updated page version to v3.2.0; added a government operating-status notice. - Removed resource: Cutaneous neuroendocrine carcinoma (no longer listed).SummaryDifference4%
- Check17 days agoChange DetectedUpdate to reflect newer dates and a newer revision (v3.1.0) while removing older timestamps and the previous revision (v3.0.2).SummaryDifference0.6%
- Check25 days agoNo Change Detected
- Check32 days agoChange DetectedUpdated the page revision from v3.0.1 to v3.0.2. Removed the non-critical 'Back to Top' element; no other core content changes were detected.SummaryDifference0.2%
- Check39 days agoChange DetectedThe web page has been updated from version 3.0.0 to 3.0.1, indicating a revision in the content. Additionally, a 'Back to Top' feature has been added for improved navigation.SummaryDifference0.2%
- Check46 days agoChange DetectedThe web page has been updated to include new resources related to cutaneous neuroendocrine carcinoma and skin cancer, while removing previous references to Merkel cell carcinoma and various antineoplastic agents. Additionally, the facility name and location details have been added.SummaryDifference13%
- Check60 days agoChange DetectedThe web page has been updated from version 2.16.11 to version 2.16.12.SummaryDifference0.1%
Stay in the know with updates to Nivo+Ipi +/- SBRT in Metastatic MCC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivo+Ipi +/- SBRT in Metastatic MCC Clinical Trial page.